Veterinary Pharmaceutical Solutions

What Veterinary Pharmaceutical Solutions does

Veterinary Pharmaceutical Solutions (VPS) is a Minnesota-based 503A licensed compounding pharmacy founded in 1995 that develops, compounds, and distributes prescription pharmaceuticals exclusively for livestock and poultry. Its product portfolio spans water-soluble antibiotics (UltrAmox, UltraFlor), NSAIDs (Meloxicam), combination antibiotic/anti-inflammatory suspensions (AmoxMelox, Enteriquell), parasiticides (Iversol), and wound-care products (Mendicin, Healicin ABF), several of which are patent-pending and supported by in-house clinical research. The core technology is pharmaceutical compounding from FDA-approved finished dosage forms under USP795 non-sterile and USP797 sterile guidelines, combined with cGMP pharmaceutical manufacturing and USDA-approved vaccine manufacturing capability acquired through Diamond Animal Health in January 2024.

VPS operates a B2B2C go-to-market: products are sold only to or through licensed veterinarians via a prescription-only model, with a veterinarian online portal for repeat orders and a field account executive team covering defined US geographic territories (notably Iowa and surrounding states and east of the Mississippi). Pricing is not publicly disclosed and is quote-based per prescription. Primary customer segments are swine producers and veterinarians, with poultry identified as an expanding vertical following the 2025 entry led by a newly hired Commercial Director, Poultry, and cattle as a secondary segment.

Ownership is held by Granite Creek Capital Partners, a Chicago-based private equity firm that acquired a majority stake from the founding Soderlund family in 2020 and funded the Diamond Animal Health acquisition. The company completed a major St. Peter, Minnesota pharmacy expansion in 2025 that nearly doubled facility size, adding multiple compounding suites, a microbiology lab, expanded R&D space and warehouse capacity, signaling ongoing reinvestment to scale the platform.

Name

Veterinary Pharmaceutical Solutions

Legal name

Veterinary Pharmaceutical Solutions

Website

https://veterinarypharmaceuticalsolutions.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

Veterinary Pharmaceutical Solutions is a Minnesota-based 503A compounding pharmacy that develops and distributes prescription pharmaceuticals exclusively for livestock and poultry through licensed veterinarians. Its portfolio spans antibiotics, combination antibiotic/anti-inflammatory therapies, NSAIDs, parasiticides, and wound-care products, several patent-pending, with cGMP manufacturing added via the 2024 Diamond Animal Health acquisition.

Ownership category

akta.pro rank

Product category

Veterinary Compounding Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAMAIAD

Compounding Pharmacies (Veterinary)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)

SECONDARYHLAMAEAB

Livestock & Production Animal Therapeutics (Rx)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

SECONDARYAFAEANAK

Veterinary Pharmacy, Vaccine & Biologics Services

Agriculture & Food Production/Animal Production & Aquaculture/Animal Health & Veterinary Services

SECONDARYHLAMAEAF

Pain Management, Anesthesia & Critical Care Drugs

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

• Veterinary compounding pharmacy
• Livestock pharmaceutical products
• Animal health medications
• Prescription veterinary drugs
• Swine poultry pharmaceuticals

Headquarters

HQ city

Saint Peter

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Prescription Veterinary Compounded Pharmaceuticals: VPS generates revenue through the sale of compounded veterinary pharmaceutical products prescribed by licensed veterinarians for livestock and poultry. Products include antibiotics, NSAIDs, parasiticides, and wound care treatments. All products require veterinarian prescription, creating a B2B2C model where veterinarians write prescriptions for livestock producers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Veterinary Pharmaceutical Solutions (VPS) operates a 503A-licensed compounding pharmacy that produces prescription-only veterinary pharmaceuticals for livestock and poultry. The company customizes medications from FDA-approved finished dosage forms, producing water-soluble antibiotics (UltrAmox), NSAIDs (Meloxicam), parasiticides (Iversol), combination therapies (AmoxMelox, Enteriquell), respiratory treatments (UltraFlor), and wound care products (Mendicin, Healicin ABF) tailored to veterinary specifications. Products are dispensed exclusively through licensed veterinarians via prescription.

Product overview

Veterinary Pharmaceutical Solutions (VPS) is a Minnesota-based 503A licensed compounding pharmacy serving the livestock and poultry industries across the United States. The company provides customized medications tailored to the unique needs of individual animals or groups of animals under veterinary supervision. VPS's product portfolio centers on its core compounding pharmacy capabilities with formulations compounded from FDA-approved finished dosage forms. The product range includes: antibiotics (UltrAmox™ water-soluble amoxicillin, Enteriquell dual-therapy combination, AmoxMelox combination therapy), NSAIDs (Meloxicam soluble and drench formulations), parasiticides (Iversol™ Ivermectin-based), respiratory treatments (UltraFlor™ florfenicol), and wound care products (Mendicin™ prescription antibiotic ointment, Healicin™ ABF non-prescription spray). The company recently expanded into poultry health with strategic hires and research presentations. VPS operates from its St. Peter, Minnesota facility and completed a major pharmacy expansion in 2025 that nearly doubled its size with multiple compounding suites, microbiology lab, and expanded R&D space.

Differentiator

Problem solved

Functional benefit

Brands

• UltrAmox: VPS-patented compounded water-soluble amoxicillin formulation for livestock and poultry
• Meloxicam
• AmoxMelox
• Enteriquell
• UltraFlor
• Iversol
• Healicin ABF
• Mendicin

Products and services

• UltrAmox™ Compounded water-soluble amoxicillin for livestock and poultry. Used to treat bacterial infections, administered via drinking water. Available in 37.5-300 gram pack sizes with miscibility options. Over 2 billion pigs, poultry and cattle treated since launch.
• Meloxicam Compounded non-steroidal anti-inflammatory drug (NSAID) available in soluble and suspension drench formulations. Used for treatment or relief of pain and inflammation in livestock. Prescription-only through veterinarians.
• Enteriquell Dual-therapy antibiotic and anti-inflammatory steroid oral solution for individual administration to piglets. Contains Tylosin, Gentamicin and Dexamethasone. Available in 500mL serum bottle with 35-day beyond-use date.
• AmoxMelox Antibiotic and anti-inflammatory suspension combining compounded Amoxicillin and Meloxicam for swine. Used for bacterial infections with need for selective COX-2 inhibiting NSAID. Available in 1-gallon (3500mL) container.
• Iversol™ Compounded soluble parasiticide containing Ivermectin for treatment of parasitic infestations in livestock caused by mange mites and lice. Formulated for use through water medicator. Prescription-only.
• UltraFlor™ Compounded water-soluble 4.25% florfenicol oral solution for livestock and poultry. Synthetic broad-spectrum antibiotic for treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, and Streptococcus suis.
• Healicin™ ABF Non-compounded antibiotic-free and steroid-free nutritive spray cream for swine wound care. No prescription necessary. Available in pint or gallon sizes with spray nozzle. Contains taste deterrent to prevent tail-biting in finishing barns.
• Mendicin™ Compounded patent-pending prescription antibiotic ointment containing Bacitracin and Neomycin for wound care in sows. Part of novel wound care product line validated by research studies.

Quantifiable outcome

• Over 2 billion pigs, poultry, and cattle treated with VPS prescription amoxicillin formulations
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Diamond Animal HealthcoreStrategic or Co-development Partner · 18 January 2023Contract manufacturer of animal health solutions acquired from Mars Corporation in January 2024. Based in Des Moines, Iowa, operates USDA, FDA, and DEA-approved facility offering R&D, regulatory licensing, contract manufacturing, and logistics. Combined with VPS creates integrated animal health platform with three pillars: FDA-approved cGMP pharmaceutical manufacturing, USDA-approved vaccine manufacturing, and Boards of Pharmacy/FDA regulated compounding.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Others

• Elanco Animal Health: Major global animal health company with broad livestock pharmaceutical portfolio. VPS's CCO and poultry leadership both came from Elanco, and Elanco's livestock antibiotics/NSAIDs compete in the same prescribing decision.

Emerging players

• Dechra Pharmaceuticals: International veterinary pharmaceuticals specialist with strong positions in species-specific therapeutics. Comparable specialty-vet-pharma orientation, though more companion animal weighted.
• Vetoquinol: Independent animal health pharmaceutical company with strong livestock and equine portfolios. Comparable size and product breadth to VPS's ambitions, particularly in anti-infectives and anti-inflammatories.
• Bimeda: Global animal health pharmaceutical manufacturer focused on livestock and companion animals. Comparable mid-sized competitor with proprietary formulations across species, overlapping VPS's therapeutic categories.
• Ceva Animal Health: Global animal health company with leading positions in poultry vaccines and livestock pharmaceuticals. Comparable in scale and species focus, particularly relevant given VPS's 2025 entry into the poultry market.
• Huvepharma: Animal health and nutrition company with manufacturing capabilities in livestock pharmaceuticals and vaccines. Comparable mid-tier positioning with integrated manufacturing and species-specialized products.

Broad incumbents

• Phibro Animal Health: Diversified global animal health and nutrition company with significant livestock pharmaceutical and vaccine portfolios. VPS's CEO Dean Warras previously led Phibro's Animal Health & Nutrition North America business, illustrating the comparable product/market overlap.
• Zoetis: Largest pure-play animal health company globally, with deep livestock and companion animal pharmaceutical franchises including antibiotics, anti-inflammatories, and vaccines. Represents the most significant competitive threat and capability benchmark.

Direct peers

• Wedgewood Pharmacy: One of the largest veterinary compounding pharmacies in the U.S., serving veterinarians with customized medications. Closest analog to VPS's compounding-from-FDA-approved-finished-dosage-forms model, although Wedgewood is more weighted to companion animals while VPS focuses on livestock.
• BCP Veterinary Pharmacy: Veterinary compounding pharmacy supplying customized medications to veterinarians. Operates in the same niche of prescription-only compounded preparations, though primarily companion animal focused.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/veterinary-pharmaceutical-solutions

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veterinary Pharmaceutical Solutions